LIFECORE BIOMEDICAL, INC. Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
LIFECORE BIOMEDICAL, INC. (LFCR) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $133.00 thousand for the 9-month period ending 2016-02-28, per its 10-Q filed 2016-03-30.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2016-03-30
- LIFECORE BIOMEDICAL, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2016-02-28 was $43.00K.
- LIFECORE BIOMEDICAL, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2015-11-29 was $16.00K, a 100.00% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2015-08-30 was $74.00K.
- LIFECORE BIOMEDICAL, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2015-03-01 was -$175.00K, a 110.09% decline year-over-year.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 3 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 6 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 9 month |
|---|---|---|---|
| 2016-02-28 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-30 | $59.00K derived: sum of 2 quarters · filed 2016-03-30 | $133.00K 10-Q · filed 2016-03-30 |
| 2015-11-29 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-07 | $90.00K 10-Q · filed 2016-01-07 | |
| 2015-08-30 | $74.00K 10-Q · filed 2015-10-01 | ||
| 2015-03-01 | -$175.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02 | -$167.00K derived: sum of 2 quarters · filed 2015-04-02 | -$211.00K 10-Q · filed 2015-04-02 |
| 2014-11-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | -$36.00K 10-Q · filed 2015-01-09 | |
| 2014-08-31 | -$44.00K 10-Q · filed 2014-10-08 | ||
| 2014-02-23 | $1.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28 | $1.91M 10-Q · filed 2014-03-28 | |
| 2013-11-24 | $175.00K 10-Q · filed 2014-01-03 | ||
| 2013-02-24 | $929.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04 | $2.24M derived: sum of 2 quarters · filed 2013-04-04 | $2.74M 10-Q · filed 2013-04-04 |
| 2012-11-25 | $1.31M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04 | $1.81M 10-Q · filed 2013-01-04 | |
| 2012-08-26 | $505.00K 10-Q/A · filed 2013-01-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |